Corline Biomedical AB (STO:CLBIO)
Sweden · Delayed Price · Currency is SEK 17.75
0.00 (0.00%)
Jul 3, 2026, 5:20 PM CET
Corline Biomedical AB Market Cap
Corline Biomedical AB has a market cap or net worth of 463.86 million as of July 2, 2026. Its market cap has increased by 91.70% in one year.
Market Cap
463.86M
Enterprise Value
436.21M
Revenue
10.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.75
Market Cap Chart
Since June 3, 2015, Corline Biomedical AB's market cap has increased from 97.97M to 463.86M, an increase of 373.50%. That is a compound annual growth rate of 15.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 463.86M | 31.61% |
| Dec 30, 2025 | 352.45M | 86.79% |
| Dec 30, 2024 | 188.69M | -41.07% |
| Dec 29, 2023 | 320.21M | 61.61% |
| Dec 30, 2022 | 198.15M | -36.85% |
| Dec 30, 2021 | 313.77M | 25.86% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Infant Bacterial Therapeutics AB | 941.65M |
| Xspray Pharma AB | 723.58M |
| AlzeCure Pharma AB | 712.47M |
| Oncopeptides AB | 649.85M |
| FluoGuide | 622.91M |
| Cantargia AB | 523.08M |
| Intervacc AB | 462.14M |
| Sprint Bioscience AB | 450.55M |